MNPR·61023L207·US·equity·Healthcare - Biotechnology-Activist
MNPR (MONOPAR THERAPEUTICS INC) is held by 53 institutional investors as of Q4 2025. Largest holders: JANUS HENDERSON GROUP PLC ($85.9M), RA CAPITAL MANAGEMENT, L.P. ($43.6M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($41.8M). Net institutional sentiment: Bullish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer